| Authors: |
Sorret L; Drug Product Services, Lonza AG, Hochbergerstrasse 60G, 4057 Basel, Switzerland., Fuentes N; Dosage Form Design and Development, BioPharmaceutical Development, R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD 20878, USA., Nonis L; Drug Product Services, Lonza AG, Hochbergerstrasse 60G, 4057 Basel, Switzerland., Damuzzo V; Hospital Pharmacy, Vittorio Veneto Hospital, AULSS2 Marca Trevigiana, Vittorio Veneto, Italy., Vozza G; Dosage Form Design and Development, BioPharmaceutical Development, R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD 20878, USA., Paulsson M; Department of Women's and Children's Health, Uppsala University, University Hospital, 751 85 Uppsala, Sweden. Electronic address: mattias.paulsson@uu.se., De Paoli G; School of Health Sciences, University of Dundee, Dundee, United Kingdom., Kwok SC; Dosage Form Design and Development, BioPharmaceutical Development, R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD 20878, USA. |
